Life Sciences & Biotechnology
Research Agricultural
Total number of Record(s): 5525
| Title | Principal Investigator | Start Year | Funding Agency | Focus Area |
|---|---|---|---|---|
| A Randomized Trial of Quadruple Fortified Salt for Anemia and Birth Defects Prevention in Southern India | Dr Wesley Bonam, Principal Investigator, Arogyavaram Medical Centre (AMC), Andhra Pradesh | 2019 | Centers for Disease Control and Prevention (CDC), Atlanta, USA | Nutrition |
| A Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide (TAF) in Adolescents with Chronic Hepatitis B Virus Infection | Dr Shalimar, Associate Professor, All India Institute of Medical Sciences (AIIMS), New Delhi | 2017 | Gilead Sciences, Inc., USA | Gastroenterology |
| A randomized, Double-blind, Placebo and Active controlled, Multicenter, Phase 3 Study to Access the Efficacy and Safety of Filgotinib Administered for 52 Weeks Alone and in Combination with Methotrexate (MTX) to Subjects with Moderately to Severely Active Rheumatoid Arthritis who Are Naive to MTX Therapy | Dr Uma Kumar, Professor & Head, All India Institute of Medical Sciences (AIIMS), New Delhi | 2018 | Gilead Sciences, Inc., USA | Orthopedics |
| A randomized, double-blind, placebo and active controlled, multicenter, phase 3 study to access the efficacy and safety of Filgotinib administered for 52 weeks in combination with Methotrexate (MTX) to subjects with moderately to severely active rheumatoid arthritis, who have an inadequate response to methotrexate | Dr Uma Kumar, Professor & Head, All India Institute of Medical Sciences (AIIMS), New Delhi | 2018 | Gilead Sciences, Inc., USA | Orthopedics |
| A Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Testicular Safety of Filgotinib in Adult Males with Moderately to Severely Active Ulcerative Colitis | Dr Saurabh Kedia, Assistant Professor, All India Institute of Medical Sciences (AIIMS), New Delhi | 2019 | Gilead Sciences, Inc., USA | Gastroenterology |
| A rapid and field deployable portable sensor for acetylcholinesterase inhibitors detection | Dr. Amitava Mukherjee, Senior Professor & Deputy Director, Centre for Nanobiotechnology, Vellore Institute of Technology (VIT) University, Tamil Nadu | 2017 | Defence Research and Development Organization (DRDO), Govt. of India | Acetylcholinesterase inhibitors detection |
| A rapid approach to generate immortalised B cells for monoclonal antibody generation from SARS-CoV-2 recovered and vaccinated group | Dr TR Santhosh Kumar, Scientist, Rajiv Gandhi Centre for Biotechnology (RGCB), Kerala | 2020 | Department of Biotechnology (DBT) Govt. of India | Monoclonal antibody generation |
| A recombinant subunit vaccine for SARS-CoV-2 | Prof Raghavan Varadarajan, Indian Institute of Science (IISc), Bengaluru | 2020 | COVID-19 Vaccine Development | |
| A Role of R7 family Regulator of G protein Signalling (RGS) proteins G bita 5 complexes in breast cancer and cell fate in the airway epithelium | Dr. Biswanath Maity, Assistant Professor, Centre of Biomedical Research (CBMR), Lucknow | 2015 | Department of Biotechnology (DBT), Govt. of India | Breast cancer |
| A SEIR model to estimate the effect of pharmaceutical and non-pharmaceutical interventions on the spread of COVID-19 | Prof Ramanathan Srinivasan, Indian Institute of Technology (IIT) Madras | 2020 | Department of Science and Technology (DST), Govt of India | Mathematical modelling for COVID-19 |